CortiCare

CortiCare

CortiCare was spun out of neurology research and clinical practice, though its exact founding year and founding principals remain undisclosed. The firm's core offering revolves around continuous EEG monitoring, where artificial intelligence triages data for human review by board-certified EEG technologists and neurologists. CortiCare deploys capital into its own technology stack — cloud infrastructure for EEG data ingestion, proprietary machine learning models trained on annotated neurology datasets, and a network of remote monitoring stations. The company does not publicly list specific portfolio investments or co-investors. Its geographic footprint covers hospital systems across the United States, with concentration in the Midwest and Southeast. The firm's workforce includes EEG technologists, data scientists, and software engineers. No additional offices are confirmed beyond Carlsbad. There are no known adjacent philanthropic or operating-company vehicles publicly associated with CortiCare. The broader remote EEG monitoring market has grown steadily, driven by increasing demand for continuous brain monitoring in ICU and epilepsy settings. CortiCare's structural differentiator is its direct integration of AI into a clinical service workflow — rather than selling software to hospitals, it sells EEG monitoring outcomes. This creates a recurring revenue model tied to patient volume, not software seats. The firm's regulatory posture includes HIPAA compliance and FDA clearance for its algorithmic components.